Zkusit zdarma
Veracyte, Inc.

Veracyte, Inc.

VCYT
Cena:
 
 
Valuace
30
Růst
100
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Here's Why Veracyte (VCYT) is a Strong Growth Stock

Here's Why Veracyte (VCYT) is a Strong Growth Stock

10:46 09-06-2026

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi...

Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?

Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?

12:35 04-06-2026

Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock?...

Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer Transcript

Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer Transcript

17:14 01-06-2026

Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and...

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

8:00 01-06-2026

On the heels of the landmark [url="]OPTIMA trial[/url] readout presented at the ASCO Annual Meeting,...

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

7:30 01-06-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #BreastCancer--Veracyte Announces Commercial ...

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

9:00 30-05-2026

[url="]Veracyte, Inc.[/url] (Nasdaq: VCYT), a leading cancer diagnostics company, today announced re...

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

8:00 30-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #ASCO26--ENZAMET Trial Shows Veracyte's Decip...

Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte's Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy

Landmark OPTIMA Trial Delivers Practice-Changing Evidence that Veracyte's Prosigna Test Identifies Patients with High-Risk Breast Cancer Who Can Safely Avoid Chemotherapy

15:15 29-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #ASCO26--OPTIMA Trial Delivers Practice-Chang...

Veracyte: The Evidence Flywheel Is Turning Into A Cash Flow Platform

Veracyte: The Evidence Flywheel Is Turning Into A Cash Flow Platform

5:17 28-05-2026

Veracyte is evolving into a multi-cancer clinical decision-making platform, leveraging evidence, pay...

Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?

Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?

12:11 27-05-2026

VCYT gains from strong Afirma and Decipher test growth, but macro pressures and competition pose ris...

Veracyte genomic test identifies breast cancer patients who can skip chemo

Veracyte genomic test identifies breast cancer patients who can skip chemo

7:22 27-05-2026

Today we feature studies to be presented at the year's most important cancer conference, the upcomin...

Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?

Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?

12:20 25-05-2026

VCYT jumps 65.8% in a year as Afirma and Decipher volumes surge, guidance lifts, and TrueMRD nears l...

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

10:51 25-05-2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t...

Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings

Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings

8:00 22-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagno...

OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

18:00 21-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #ASCO26--OPTIMA Trial Results to Be Presented...

Veracyte to Participate in Upcoming Investor Conferences

Veracyte to Participate in Upcoming Investor Conferences

16:05 19-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) announced today that the...

Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term

Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term

10:45 18-05-2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the ...

Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer

Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer

9:00 15-05-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT #BladderCancer--Veracyte Secures Medicare Cov...

Veracyte Inc (VCYT) Shares Fall 3.3% -- What GF Score of 82 Tells Investors

Veracyte Inc (VCYT) Shares Fall 3.3% -- What GF Score of 82 Tells Investors

20:19 13-05-2026

On May 13, 2026, Veracyte Inc (VCYT) shares fell 3.3%, bringing the current price to $38.26. The sto...

Why Veracyte Stock Is Skyrocketing Higher This Week

Why Veracyte Stock Is Skyrocketing Higher This Week

0:51 08-05-2026

Veracyte grew revenue by 21% in Q1 and saw earnings per share quadruple from last year, as margins b...

close

VERACYTE TO RELEASE FOURTH QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 25, 2026

04-02-2026
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

11-01-2026
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE TO PARTICIPATE IN THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

29-12-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

06-11-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT) A LEADING CANCER DIAGNOS...
Více zde

VERACYTE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS

04-11-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE ANNOUNCES FIRST PUBLICATIONS USING AFIRMA GRID RESEARCH TOOL TO HELP USHER IN NEXT GENERATION OF THYROID NODULE TESTING

03-11-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VYCT #AFIRMAGRID--VERACYTE, INC. (NASDAQ: VCYT), A...
Více zde

VERACYTE TO RELEASE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 4, 2025

15-10-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE ANNOUNCES THAT DECIPHER-ENABLED BIOMARKER PREDICTS HORMONE THERAPY BENEFIT IN MEN WITH RECURRENT PROSTATE CANCER

28-09-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VYCT #ASTRO25--VERACYTE, INC. (NASDAQ: VCYT), A LE...
Více zde

VERACYTE ANNOUNCES FIRST PROSPECTIVE VALIDATION DATA FOR BIOMARKER PREDICTING HORMONE THERAPY BENEFIT IN MEN WITH RECURRENT PROSTATE CANCER WILL BE PRESENTED AT ASTRO 2025

24-09-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VYCT #ASTRO25--VERACYTE, INC. (NASDAQ: VCYT), A LE...
Více zde

VERACYTE ANNOUNCES THAT MORE THAN 10 AFIRMA-FOCUSED STUDIES WILL BE PRESENTED AT THE 2025 AMERICAN THYROID ASSOCIATION ANNUAL MEETING

09-09-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE TO PARTICIPATE IN THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

29-08-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT) ANNOUNCED TODAY THAT MAN...
Více zde

VERACYTE ANNOUNCES NEW STUDY PUBLISHED IN CELL SHOWS THAT DECIPHER PROSTATE TEST PREDICTS CHEMOTHERAPY BENEFIT IN PATIENTS WITH METASTATIC PROSTATE CANCER

27-08-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES NEW STUDY IN CELL SHOWS T...
Více zde

VERACYTE COMPLETES NIGHTINGALE CLINICAL UTILITY TRIAL ENROLLMENT FOR PERCEPTA NASAL SWAB LUNG CANCER TEST

26-08-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE COMPLETES NIGHTINGALE CLINICAL UTIL...
Více zde

VERACYTE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS

06-08-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE SET TO JOIN S&P SMALLCAP 600

24-07-2025
NEW YORK , JULY 24, 2025 /PRNEWSWIRE/ -- VERACYTE INC. (NASD: VCYT) WILL REPLACE TRIUMPH GROUP INC. ...
Více zde

VERACYTE TO RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 6, 2025

17-07-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE ANNOUNCES THAT MULTIPLE AFIRMA GRID STUDIES WILL BE PRESENTED AT ENDO 2025

08-07-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES THAT MULTIPLE AFIRMA GRID...
Více zde

VERACYTE ANNOUNCES MULTIPLE ABSTRACTS TO BE PRESENTED AT ASCO, DEMONSTRATING POWER OF DECIPHER GRID TO ADVANCE NEW PROSTATE AND BLADDER CANCER RESEARCH

28-05-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES MULTIPLE ABSTRACTS TO BE ...
Více zde

VERACYTE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

20-05-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT) A LEADING CANCER DIAGNOS...
Více zde

VERACYTE ANNOUNCES EXPANDED AVAILABILITY OF DECIPHER PROSTATE TEST TO PATIENTS WITH METASTATIC PROSTATE CANCER

25-04-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES EXPANDED AVAILABILITY OF ...
Více zde

VERACYTE ANNOUNCES MULTIPLE ABSTRACTS DEMONSTRATING POWER OF DECIPHER TESTING TO FUEL NEW PROSTATE AND BLADDER CANCER INSIGHTS WILL BE PRESENTED AT AUA ANNUAL MEETING

22-04-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES MULTIPLE ABSTRACTS DEMONS...
Více zde

VERACYTE ANNOUNCES DECIPHER PROSTATE GENOMIC CLASSIFIER RESULTS ARE LINKED TO REAL-WORLD DATA IN NATIONAL CANCER INSTITUTE'S SEER SPECIALIZED DATABASE RELEASE

21-04-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES DECIPHER PROSTATE GENOMIC...
Více zde

NEW DATA DEMONSTRATE ACCURACY OF VERACYTE'S WHOLE-GENOME SEQUENCING-BASED MRD TESTING PLATFORM FOR MUSCLE-INVASIVE BLADDER CANCER

25-03-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--NEW DATA DEMONSTRATE ACCURACY OF VERACYTE'S ...
Více zde

VERACYTE ANNOUNCES EIGHT ABSTRACTS HIGHLIGHTING PERFORMANCE AND CLINICAL UTILITY OF ITS DECIPHER AND MRD TESTS IN UROLOGIC CANCERS TO BE PRESENTED AT EAU25

19-03-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE ANNOUNCES 8 ABSTRACTS HIGHLIGHTING ...
Více zde

VERACYTE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

24-02-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT) TODAY ANNOUNCED FINANCIA...
Více zde

VERACYTE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

19-02-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT) A LEADING CANCER DIAGNOS...
Více zde

NEW DATA AT ASCO GU SHOW POWER OF VERACYTE'S DECIPHER TESTS TO IMPROVE PATIENT CARE AND ITS GRID TOOL TO ADVANCE PROSTATE AND BLADDER CANCER RESEARCH

14-02-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--NEW DATA AT ASCO GU SHOW POWER OF VERACYTE'S...
Více zde

NEW STUDY SHOWS VERACYTE'S DECIPHER BLADDER TEST PREDICTS DISEASE UPSTAGING IN PATIENTS WITH BLADDER CANCER

05-02-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--NEW STUDY SHOWS VERACYTE'S DECIPHER BLADDER ...
Více zde

VERACYTE TO RELEASE FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS ON FEBRUARY 24, 2025

04-02-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNO...
Více zde

VERACYTE'S DECIPHER PROSTATE TEST IS NOW THE ONLY GENE EXPRESSION TEST RECOMMENDED IN NCCN® PROSTATE CANCER GUIDELINES

05-12-2024
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)---- $VCYT--VERACYTE'S DECIPHER PROSTATE TEST IS NOW THE...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-11-04 00:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 00:00:008-KStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-05-07 01:00:008-KStáhnout
2025-05-07 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-24 00:00:008-KStáhnout
2025-02-23 23:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-05 23:00:008-KStáhnout
2024-09-04 01:00:008-KStáhnout
2024-09-04 00:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 00:00:008-KStáhnout
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-13 00:00:008-KStáhnout
2024-02-12 23:00:008-KStáhnout
2024-02-06 00:00:008-KStáhnout
2024-02-05 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-08 00:00:0010-QStáhnout
2023-11-07 23:00:0010-QStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-06 23:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-05 01:00:0010-QStáhnout
2023-05-05 00:00:0010-QStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 00:00:008-KStáhnout
2023-03-01 00:00:0010-KStáhnout
2023-02-28 23:00:0010-KStáhnout
2023-02-22 00:00:008-KStáhnout
2023-02-21 23:00:008-KStáhnout
2023-02-10 00:00:008-KStáhnout
2023-02-09 23:00:008-KStáhnout
2022-12-14 00:00:008-KStáhnout
2022-12-13 23:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-11-02 00:00:008-KStáhnout
2022-11-01 23:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-08-02 01:00:008-KStáhnout
2022-08-02 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 00:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-01-11 00:00:008-KStáhnout
2022-01-10 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 00:00:008-KStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 00:00:008-KStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 01:00:0010-QStáhnout
2021-07-29 00:00:008-KStáhnout
2021-07-29 00:00:0010-QStáhnout
2021-07-16 01:00:008-KStáhnout
2021-07-16 00:00:008-KStáhnout
2021-07-13 01:00:008-KStáhnout
2021-07-13 00:00:008-KStáhnout
2021-07-12 01:00:008-KStáhnout
2021-07-12 00:00:008-KStáhnout
2021-06-08 01:00:008-KStáhnout
2021-06-08 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-05-19 01:00:008-KStáhnout
2021-05-19 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-04-15 01:00:008-KStáhnout
2021-04-15 00:00:008-KStáhnout
2021-04-05 01:00:008-KStáhnout
2021-04-05 00:00:008-KStáhnout
2021-03-22 00:00:008-KStáhnout
2021-03-21 23:00:008-KStáhnout
2021-03-15 00:00:008-KStáhnout
2021-03-14 23:00:008-KStáhnout
2021-03-03 00:00:008-KStáhnout
2021-03-02 23:00:008-KStáhnout
2021-02-22 00:00:0010-KStáhnout
2021-02-21 23:00:0010-KStáhnout
2021-02-17 00:00:008-KStáhnout
2021-02-16 23:00:008-KStáhnout
2021-02-05 00:00:008-KStáhnout
2021-02-04 23:00:008-KStáhnout
2021-02-03 00:00:008-KStáhnout
2021-02-02 23:00:008-KStáhnout
2021-01-25 00:00:008-KStáhnout
2021-01-24 23:00:008-KStáhnout
2020-12-16 00:00:008-KStáhnout
2020-12-15 23:00:008-KStáhnout
2020-11-17 00:00:008-KStáhnout
2020-11-16 23:00:008-KStáhnout
2020-11-02 00:00:008-KStáhnout
2020-11-02 00:00:0010-QStáhnout
2020-11-01 23:00:008-KStáhnout
2020-11-01 23:00:0010-QStáhnout
2020-08-05 01:00:008-KStáhnout
2020-08-05 00:00:008-KStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 01:00:0010-QStáhnout
2020-07-30 00:00:008-KStáhnout
2020-07-30 00:00:0010-QStáhnout
2020-07-27 01:00:008-KStáhnout
2020-07-27 00:00:008-KStáhnout
2020-06-09 01:00:008-KStáhnout
2020-06-09 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-04-16 01:00:008-KStáhnout
2020-04-16 00:00:008-KStáhnout
2020-04-14 01:00:008-KStáhnout
2020-04-14 00:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-02-25 00:00:008-KStáhnout
2020-02-25 00:00:0010-KStáhnout
2020-02-24 23:00:008-KStáhnout
2020-02-24 23:00:0010-KStáhnout
2019-12-03 00:00:008-KStáhnout
2019-12-02 23:00:008-KStáhnout
2019-10-22 01:00:008-KStáhnout
2019-10-22 01:00:0010-QStáhnout
2019-10-22 00:00:008-KStáhnout
2019-10-22 00:00:0010-QStáhnout
2019-07-30 01:00:008-KStáhnout
2019-07-30 01:00:0010-QStáhnout
2019-07-30 00:00:008-KStáhnout
2019-07-30 00:00:0010-QStáhnout
2019-06-28 01:00:008-KStáhnout
2019-06-28 00:00:008-KStáhnout
2019-06-11 01:00:008-KStáhnout
2019-06-11 00:00:008-KStáhnout
2019-05-03 01:00:008-KStáhnout
2019-05-03 00:00:008-KStáhnout
2019-04-30 01:00:008-KStáhnout
2019-04-30 01:00:0010-QStáhnout
2019-04-30 00:00:008-KStáhnout
2019-04-30 00:00:0010-QStáhnout
2019-04-26 01:00:008-KStáhnout
2019-04-26 00:00:008-KStáhnout
2019-02-26 00:00:008-KStáhnout
2019-02-25 23:00:008-KStáhnout
2019-02-25 00:00:008-KStáhnout
2019-02-25 00:00:0010-KStáhnout
2019-02-24 23:00:008-KStáhnout
2019-02-24 23:00:0010-KStáhnout
2019-01-03 00:00:008-KStáhnout
2019-01-02 23:00:008-KStáhnout
2018-10-29 00:00:008-KStáhnout
2018-10-29 00:00:0010-QStáhnout
2018-10-28 23:00:008-KStáhnout
2018-10-28 23:00:0010-QStáhnout
2018-10-26 01:00:008-KStáhnout
2018-10-26 00:00:008-KStáhnout
2018-07-26 01:00:008-KStáhnout
2018-07-26 00:00:008-KStáhnout
2018-07-23 01:00:008-KStáhnout
2018-07-23 01:00:0010-QStáhnout
2018-07-23 00:00:008-KStáhnout
2018-07-23 00:00:0010-QStáhnout
2018-06-06 01:00:008-KStáhnout
2018-06-06 00:00:008-KStáhnout
2018-05-01 01:00:008-KStáhnout
2018-05-01 01:00:0010-QStáhnout
2018-05-01 00:00:008-KStáhnout
2018-05-01 00:00:0010-QStáhnout
2018-02-28 00:00:008-KStáhnout
2018-02-27 23:00:008-KStáhnout
2018-02-27 00:00:008-KStáhnout
2018-02-27 00:00:0010-KStáhnout
2018-02-26 23:00:008-KStáhnout
2018-02-26 23:00:0010-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-10-20 01:00:008-KStáhnout
2017-10-20 00:00:008-KStáhnout
2017-08-17 01:00:008-KStáhnout
2017-08-17 00:00:008-KStáhnout
2017-07-31 01:00:008-KStáhnout
2017-07-31 01:00:0010-QStáhnout
2017-07-31 00:00:008-KStáhnout
2017-07-31 00:00:0010-QStáhnout
2017-06-06 01:00:008-KStáhnout
2017-06-06 00:00:008-KStáhnout
2017-05-03 01:00:008-KStáhnout
2017-05-03 01:00:0010-QStáhnout
2017-05-03 00:00:008-KStáhnout
2017-05-03 00:00:0010-QStáhnout
2017-03-06 00:00:008-KStáhnout
2017-03-05 23:00:008-KStáhnout
2017-03-01 00:00:008-KStáhnout
2017-03-01 00:00:0010-KStáhnout
2017-02-28 23:00:008-KStáhnout
2017-02-28 23:00:0010-KStáhnout
2016-12-13 00:00:008-KStáhnout
2016-12-12 23:00:008-KStáhnout
2016-11-23 00:00:008-KStáhnout
2016-11-22 23:00:008-KStáhnout
2016-11-21 00:00:008-KStáhnout
2016-11-20 23:00:008-KStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:008-KStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-11-02 00:00:008-KStáhnout
2016-11-01 23:00:008-KStáhnout
2016-11-01 00:00:008-KStáhnout
2016-10-31 23:00:008-KStáhnout
2016-10-19 01:00:008-KStáhnout
2016-10-19 00:00:008-KStáhnout
2016-10-03 01:00:008-KStáhnout
2016-10-03 00:00:008-KStáhnout
2016-08-03 01:00:008-KStáhnout
2016-08-03 01:00:0010-QStáhnout
2016-08-03 00:00:008-KStáhnout
2016-08-03 00:00:0010-QStáhnout
2016-06-17 01:00:008-KStáhnout
2016-06-17 00:00:008-KStáhnout
2016-06-13 01:00:008-KStáhnout
2016-06-13 00:00:008-KStáhnout
2016-05-05 01:00:008-KStáhnout
2016-05-05 01:00:0010-QStáhnout
2016-05-05 00:00:008-KStáhnout
2016-05-05 00:00:0010-QStáhnout
2016-03-30 01:00:008-KStáhnout
2016-03-30 00:00:008-KStáhnout
2016-03-28 01:00:008-KStáhnout
2016-03-28 00:00:008-KStáhnout
2016-03-14 00:00:0010-KStáhnout
2016-03-13 23:00:0010-KStáhnout
2016-03-10 00:00:008-KStáhnout
2016-03-09 23:00:008-KStáhnout
2016-03-04 00:00:008-KStáhnout
2016-03-03 23:00:008-KStáhnout
2015-11-24 00:00:008-KStáhnout
2015-11-23 23:00:008-KStáhnout
2015-11-16 00:00:008-KStáhnout
2015-11-15 23:00:008-KStáhnout
2015-11-05 00:00:008-KStáhnout
2015-11-05 00:00:0010-QStáhnout
2015-11-04 23:00:008-KStáhnout
2015-11-04 23:00:0010-QStáhnout
2015-09-29 01:00:008-KStáhnout
2015-09-29 00:00:008-KStáhnout
2015-08-13 01:00:008-KStáhnout
2015-08-13 01:00:0010-QStáhnout
2015-08-13 00:00:008-KStáhnout
2015-08-13 00:00:0010-QStáhnout
2015-05-19 01:00:008-KStáhnout
2015-05-19 00:00:008-KStáhnout
2015-05-15 01:00:0010-QStáhnout
2015-05-15 00:00:0010-QStáhnout
2015-05-14 01:00:008-KStáhnout
2015-05-14 00:00:008-KStáhnout
2015-05-01 01:00:008-KStáhnout
2015-05-01 00:00:008-KStáhnout
2015-04-24 01:00:008-KStáhnout
2015-04-24 00:00:008-KStáhnout
2015-04-07 01:00:008-KStáhnout
2015-04-07 00:00:008-KStáhnout
2015-03-31 01:00:008-KStáhnout
2015-03-31 00:00:008-KStáhnout
2015-03-25 00:00:0010-KStáhnout
2015-03-24 23:00:0010-KStáhnout
2015-03-19 00:00:008-KStáhnout
2015-03-18 23:00:008-KStáhnout
2015-03-13 00:00:008-KStáhnout
2015-03-12 23:00:008-KStáhnout
2015-03-05 00:00:008-KStáhnout
2015-03-04 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2014-12-18 00:00:008-KStáhnout
2014-12-17 23:00:008-KStáhnout
2014-11-13 00:00:008-KStáhnout
2014-11-13 00:00:0010-QStáhnout
2014-11-12 23:00:008-KStáhnout
2014-11-12 23:00:0010-QStáhnout
2014-09-17 01:00:008-KStáhnout
2014-09-17 00:00:008-KStáhnout
2014-09-04 01:00:008-KStáhnout
2014-09-04 00:00:008-KStáhnout
2014-08-14 01:00:0010-QStáhnout
2014-08-14 00:00:0010-QStáhnout
2014-08-13 01:00:008-KStáhnout
2014-08-13 00:00:008-KStáhnout
2014-07-14 01:00:008-KStáhnout
2014-07-14 00:00:008-KStáhnout
2014-06-10 01:00:008-KStáhnout
2014-06-10 00:00:008-KStáhnout
2014-05-20 01:00:008-KStáhnout
2014-05-20 00:00:008-KStáhnout
2014-05-09 01:00:0010-QStáhnout
2014-05-09 00:00:0010-QStáhnout
2014-05-08 01:00:008-KStáhnout
2014-05-08 00:00:008-KStáhnout
2014-03-20 00:00:0010-KStáhnout
2014-03-19 23:00:0010-KStáhnout
2014-03-18 00:00:008-KStáhnout
2014-03-17 23:00:008-KStáhnout
2014-03-07 00:00:008-KStáhnout
2014-03-06 23:00:008-KStáhnout
2014-02-25 00:00:008-KStáhnout
2014-02-24 23:00:008-KStáhnout
2013-11-25 00:00:008-KStáhnout
2013-11-25 00:00:0010-QStáhnout
2013-11-24 23:00:008-KStáhnout
2013-11-24 23:00:0010-QStáhnout
2013-11-08 00:00:008-KStáhnout
2013-11-07 23:00:008-KStáhnout
preloader